New Drug Controller of India (DCGI) takes over

New Delhi: Dr Eshwar Reddy is the new Drug Controller of India (DCGI). He takes over the charge from Dr G.N. Singh.

Dr Reddy bucks the trend in the sense that he is not a political appointee. He is from within the department and is seized of a well thought out Pharma vision 2030.  Perhaps After a long time, he is a professional appointee as in the past most DCGI were political nominations from outside department. For long term Pharma vision, he is considered the most eligible one for this post.

Dr Reddy has leadership qualities and it is hugely hoped that he would come out with flying colours during his three month probation. Medical device sector has been his pet subject.

Rajiv Nath, Forum Coordinator, Association of Indian Medical device industry (AiMeD), has expressed utmost pleasure on his appointment and not being a political appointee. Dr Reddy was joint drug controller of India.

  • Related Posts

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    New Delhi: Alembic Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Levothyroxine Sodium Tablets USP in…

    STF busts fake meds racket spread across 6 states

    Dehradun: Uttarakhand special task force (STF) on Friday busted an online fake medicine racket operating through a Facebook page that allegedly sold counterfeit drugs, including cancer medicines, at discounts of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

    STF busts fake meds racket spread across 6 states

    STF busts fake meds racket spread across 6 states

    All the Way from Teeth to Tee: Hole in One

    All the Way from Teeth to Tee: Hole in One

    Zydus Lifesciences Q4FY26 net profit rises 9%

    Zydus Lifesciences Q4FY26 net profit rises 9%

    Chemists strike on May 20: Reasons behind today’s all-India strike

    Chemists strike on May 20: Reasons behind today’s all-India strike

    AbbVie loses patent plea for Hep C drug

    AbbVie loses patent plea for Hep C drug